These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8831897)

  • 1. Immunoactive products of placenta. V. Immunoregulatory properties of a low molecular weight compound obtained from human placental cultures.
    Djian V; Menu E; Thibault G; Ropert S; Chaouat G
    Am J Reprod Immunol; 1996 Jul; 36(1):11-24. PubMed ID: 8831897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of transient murine T cell anergy by a low molecular weight compound obtained from supernatants of human placental cultures is linked to defective phosphorylation of TCR CD3 chain.
    Voluménie JL; Mognetti B; de Smedt D; Menu E; Chaouat G
    Am J Reprod Immunol; 1997 Sep; 38(3):168-75. PubMed ID: 9325488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoactive products of placenta. VI. Induction of transient murine T cell anergy by a low-molecular-weight compound obtained from supernatants of human placental cultures.
    de Smedt D; Menu E; Chaouat G
    Cell Immunol; 1997 Feb; 175(2):128-40. PubMed ID: 9023418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activity of the suppressor cells inducer factor secreted by the Jeg-3 choriocarcinoma cell line.
    Markert UR; Chaouat G
    Am J Reprod Immunol; 2001 Nov; 46(5):332-41. PubMed ID: 11712762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythroid cells in immunoregulation: characterization of a novel suppressor factor.
    Seledtsova GV; Seledtsov VI; Samarin DM; Senyukov VV; Ivanova IP; Akimenko ZA; Tsyrlova IG; Wolpe SS; Kozlov VA
    Immunol Lett; 2004 May; 93(2-3):171-8. PubMed ID: 15158614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoactive products of human placenta. IV. Immunoregulatory factors obtained from cultures of human placenta inhibit in vivo local and systemic allogeneic and graft versus-host reactions in mice.
    Menu E; Kinsky R; Hoffman M; Chaouat G
    J Reprod Immunol; 1991 Sep; 20(3):195-204. PubMed ID: 1960703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive properties of human placenta: study of supernatants from short-term syncytiotrophoblast cultures.
    Culouscou JM; Remacle-Bonnet MM; Pommier G; Rance RJ; Depieds RC
    J Reprod Immunol; 1986 Apr; 9(1):33-47. PubMed ID: 3023607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoactive products of human placenta. I. An immunoregulatory factor obtained from explant cultures of human placenta inhibits CTL generation and cytotoxic effector activity.
    Menu E; Kaplan L; Andreu G; Denver L; Chaouat G
    Cell Immunol; 1989 Apr; 119(2):341-52. PubMed ID: 2522822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation of placental-eluted gamma globulin and its immunosuppressive effect in vitro and in vivo].
    Liu F; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):529-34. PubMed ID: 16800936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation.
    Kudo Y; Boyd CA; Sargent IL; Redman CW
    J Physiol; 2001 Aug; 535(Pt 1):207-15. PubMed ID: 11507170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cytolytic T lymphocyte maturation with ornithine, arginine, and putrescine.
    Susskind BM; Chandrasekaran J
    J Immunol; 1987 Aug; 139(3):905-12. PubMed ID: 2955052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells.
    Mulé JJ; Schwarz SL; Roberts AB; Sporn MB; Rosenberg SA
    Cancer Immunol Immunother; 1988; 26(2):95-100. PubMed ID: 2452015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Status of T- and B-lymphocytes in long living CBA--F1 (CBA X C57BL/6) chimeras].
    Cherniakhovskaia IIu; Nesterenko VG; Filitis LN; Fontalin LN; Novikova TK
    Biull Eksp Biol Med; 1978 Aug; 86(8):197-200. PubMed ID: 28802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble factors secreted by naturally occurring suppressor cells that interfere with in vivo graft-vs.-host disease and with T cell responsiveness in vitro.
    Knaan-Shanzer S; Van Bekkum DW
    Eur J Immunol; 1987 Jun; 17(6):827-34. PubMed ID: 2954829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of in vitro lymphocyte proliferation by ovine placenta-conditioned culture medium.
    Low BG; Hansen PJ; Drost M
    J Reprod Immunol; 1991 Jan; 19(1):25-41. PubMed ID: 2007994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive applications of PHA and other plant mitogens.
    Wimer BM
    Cancer Biother Radiopharm; 1998 Apr; 13(2):99-107. PubMed ID: 10850346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines.
    Orosz CG; Zinn NE; Olsen RG; Mathes LE
    J Immunol; 1985 May; 134(5):3396-403. PubMed ID: 2984289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector activity of decidual CD8+ T lymphocytes in early human pregnancy.
    Scaife PJ; Bulmer JN; Robson SC; Innes BA; Searle RF
    Biol Reprod; 2006 Oct; 75(4):562-7. PubMed ID: 16822900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.